Abstract
Purpose
Daytime sleepiness, a frequent symptom of obstructive sleep apnea (OSA), can impact functional status. In patients with coronary artery disease (CAD) and concomitant OSA, the distinction between sleep-related functional impairment from underlying CAD versus OSA is unclear. This study evaluated the impact of OSA on sleep-related functional impairment in patients with CAD and compared the effect of 1-year continuous positive airway pressure (CPAP) use on change in impairment between those with and without excessive daytime sleepiness (EDS) and OSA. We hypothesized that sleep-related functional impairment is impacted by EDS independent of OSA in patients with CAD.
Methods
One hundred five CAD patients without OSA and 105 with moderate-to-severe OSA from the RICCADSA trial were matched on disease severity and included in the current substudy. Of those with OSA, 80 were allocated to CPAP. Functional Outcomes of Sleep Questionnaire (FOSQ) score < 17.9 corresponded to sleep-related functional impairment.
Results
Following revascularization, CAD patients with and without OSA frequently report sleep-related functional impairment (35% and 27.3%, respectively; p = .29). Moderate-to-severe OSA was not related to baseline FOSQ scores < 17.9 in regression analyses; EDS was (OR 4.82, 95% CI 2.12–11.0; p < .001). CPAP use significantly improved FOSQ scores from baseline to 1-year follow-up in OSA patients with EDS (17.2 ± 2.0 to 18.15 ± 1.7, p = .002) despite suboptimal adherence.
Conclusions
Sleep-related functional impairment may be reflective of persistent EDS, independent of OSA. Diagnosing OSA and initiating treatment are worthwhile in individuals with CAD and EDS, as both are important to guide appropriate therapy in patients with CAD.
Similar content being viewed by others
References
Rumsfeld JS, Alexander KP, Goff DC et al (2013) Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation 127(22):2233–2249. https://doi.org/10.1161/CIR.0b013e3182949a2e
Kaul P, Naylor CD, Armstrong PW, Mark DB, Theroux P, Dagenais GR (2009) Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. Can J Cardiol 25(7):e225–e231. https://doi.org/10.1016/S0828-282X(09)70506-9
Wolff G, Dimitroulis D, Andreotti F, Kołodziejczak M, Jung C, Scicchitano P, Devito F, Zito A, Occhipinti M, Castiglioni B, Calveri G, Maisano F, Ciccone MM, de Servi S, Navarese EP (2017) Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease. Circ Hear Fail 10(1):e003255. https://doi.org/10.1161/CIRCHEARTFAILURE.116.003255
Smith SC, Benjamin EJ, Bonow RO et al (2011) AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124(22):2458–2473. https://doi.org/10.1161/CIR.0b013e318235eb4d
Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 13(3):479–504. https://doi.org/10.5664/jcsm.6506
Glantz H, Thunstroöm E, Herlitz J et al (2013) Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort. Ann Am Thorac Soc 10(4):350–356. https://doi.org/10.1513/AnnalsATS.201211-106OC
Zhang J-J, Gao X-F, Ge Z, Jiang XM, Xiao PX, Tian NL, Kan J, Lee CH, Chen SL (2016) Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention. Patient Prefer Adherence 10:871–878
Lee C-H, Sethi R, Li R, Ho HH, Hein T, Jim MH, Loo G, Koo CY, Gao XF, Chandra S, Yang XX, Furlan SF, Ge Z, Mundhekar A, Zhang WW, Uchôa CHG, Kharwar RB, Chan PF, Chen SL, Chan MY, Richards AM, Tan HC, Ong TH, Roldan G, Tai BC, Drager LF, Zhang JJ (2016) Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation 133(21):2008–2017. https://doi.org/10.1161/CIRCULATIONAHA.115.019392
Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GAJ, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13(1):68–75. https://doi.org/10.1093/eurjhf/hfq183
O’Connor CM, Whellan DJ, Fiuzat M, Punjabi NM, Tasissa G, Anstrom KJ, Benjafield AV, Woehrle H, Blase AB, Lindenfeld JA, Oldenburg O (2017) Cardiovascular outcomes with minute ventilation–targeted adaptive servo-ventilation therapy in heart failure: the CAT-HF trial. J Am Coll Cardiol 69(12):1577–1587. https://doi.org/10.1016/j.jacc.2017.01.041
McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi-Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS, SAVE Investigators and Coordinators (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931. https://doi.org/10.1056/NEJMoa1606599
Gooneratne NS, Weaver TE, Cater JR, Pack FM, Arner HM, Greenberg AS, Pack AI (2003) Functional outcomes of excessive daytime sleepiness in older adults. J Am Geriatr Soc 51(5):642–649. https://doi.org/10.1034/j.1600-0579.2003.00208.x
Gu G, Zhou Y, Zhang Y, Cui W (2016) Increased prevalence of anxiety and depression symptoms in patients with coronary artery disease before and after percutaneous coronary intervention treatment. BMC Psychiatry 16(1):1–9. https://doi.org/10.1186/s12888-016-0972-9
Barnason SA, Zimmerman LM, Brey B, Catlin S, Nieveen JL (2006) Patterns of recovery following percutaneous coronary intervention: a pilot study. Appl Nurs Res 19(1):31–37. https://doi.org/10.1016/j.apnr.2004.12.002
Weaver TE, Mancini C, Maislin G, Cater J, Staley B, Landis JR, Ferguson KA, George CFP, Schulman DA, Greenberg H, Rapoport DM, Walsleben JA, Lee-Chiong T, Gurubhagavatula I, Kuna ST (2012) Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med 186(7):677–683. https://doi.org/10.1164/rccm.201202-0200OC
Weaver TE, Maislin G, Dinges DF et al (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719. https://doi.org/10.1016/S8756-3452(08)70707-2
Walia HK, Thompson NR, Katzan I, Foldvary-Schaefer N, Moul DE, Mehra R (2017) Impact of sleep-disordered breathing treatment on quality of life measures in a large clinic-based cohort. J Clin Sleep Med 13(11):1255–1263
Antic NA, Catcheside P, Buchan C et al (2011) The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34(1):111–119. https://doi.org/10.1016/j.yneu.2011.05.056
Peker Y, Glantz H, Thunström E, Kallryd A, Herlitz J, Ejdebäck J (2009) Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial. Scand Cardiovasc J 43(1):24–31. https://doi.org/10.1080/14017430802276106
Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, Smith PL, Schwartz AR, Redline S, Pack AI, Dinges DF (1997) An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 20(10):835–843 http://www.ncbi.nlm.nih.gov/pubmed/9415942
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545. https://doi.org/10.1016/j.sleep.2007.08.004
Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15(4):376–381. https://doi.org/10.1093/sleep/15.4.376
Pallant J SPSS survival manual, a step by step guide to data analysis using SPSS for windows, vol 2007, 3rd edn. McGraw Hill, Sydney, pp 179–200
Cohen J (1992) A power primer. Quant Methods Psychol 112(1):155–159. https://doi.org/10.1037/0033-2909.112.1.155
Weaver EM, Woodson BT, Steward DL (2005) Polysomnography indexes are discordant with quality of life, symptoms, and reaction times in sleep apnea patients. Otolaryngol - Head Neck Surg 132(2):255–262. https://doi.org/10.1016/j.otohns.2004.11.001
Khan A, Harrison SL, Kezirian EJ, Ancoli-Israel S, O’Hearn D, Orwoll E, Redline S, Ensrud K, Stone KL (2013) Obstructive sleep apnea during rapid eye movement sleep, daytime sleepiness, and quality of life in older men in Osteoporotic Fractures in Men (MrOS) Sleep Study. J Clin Sleep Med 9(3):191–198. https://doi.org/10.5664/jcsm.2474
Kezirian EJ, Harrison SL, Ancoli-Israel S, Redline S, Ensrud K, Goldberg AN, Claman DM, Spira AP, Stone KL, for the Study of Osteoporotic Fractures in Men (MrOS) Research Group (2009) Behavioral correlates of sleep-disordered breathing in older men. Sleep 32(2):253–261 http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105447435&site=ehost-live
Billings ME, Rosen CL, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Zee PC, Redline S, Kapur VK (2014) Psychometric performance and responsiveness of the functional outcomes of sleep questionnaire and sleep apnea quality of life index in a randomized trial: the HomePAP study. Sleep 37(12):2017–2024. https://doi.org/10.5665/sleep.4262
Rosendorff C, Lackland DT, Allison M et al (2015) Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension 65:000–000. https://doi.org/10.1161/HYP.0000000000000018
Valipour A, Lothaller H, Rauscher H, Zwick H, Burghuber OC, Lavie P (2007) Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep 30(3):312–319
Acknowledgements
We gratefully acknowledge the Swedish Research Council (521-2011-537 and 521-2013-3439), the Swedish Heart-Lung Foundation (20080592, 20090708, 20100664, and 20110469), the “Agreement concerning research and education of doctors” of Vastra Gotalandsregionen (ALFGBG-11538 and ALFGBG-150801), the research fund at Skaraborg Hospital, the Skaraborg Research and Development Council, the Heart Foundation of Kärnsjukhuset, and the ResMed Foundation and ResMed Ltd. for the research grants that supported the parent RICCADSA study.
Funding
The National Institute of Health Heart Lung and Blood Institute provided financial support in the form of an institutional grant, Translational Sleep Medicine (HL82610) at the University of Pittsburgh School of Medicine. The sponsor had no role in the design or conduct of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. However, Thunström received consultant fees from ResMed and Pfizer outside the submitted work. Strollo received institutional grants from Philips-Respironics, ResMed, Inspire Medical Systems, and National Football League PinMed, and advisory fees from ResMed, Emmi Solutions, Jazz Pharmaceuticals, Itamar Medical, Inspire Medical Systems, and Separation Design Group, all outside the submitted work. Peker received institutional grants from ResMed for the main RICCADSA trial, consultant fees from BresoTec, and lecture fees from ResMed and Philips-Respironics all outside the submitted work.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Baniak, L.M., Chasens, E.R., Luyster, F.S. et al. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial. Sleep Breath 22, 1169–1177 (2018). https://doi.org/10.1007/s11325-018-1733-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-018-1733-4